• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 66
  • 56
  • 7
  • 5
  • 5
  • 2
  • 1
  • Tagged with
  • 160
  • 160
  • 32
  • 28
  • 21
  • 19
  • 19
  • 19
  • 18
  • 16
  • 15
  • 14
  • 13
  • 13
  • 13
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
41

Role of Glucocorticoid Receptor and Mineralocorticoid Receptor in Controlling Amphibian Metamorphosis

Sterner, Zachary 23 May 2022 (has links)
No description available.
42

Thyroid Hormone Modulates Zebrafish Pectoral Fin Development

Ranieri, Isabella January 2023 (has links)
Thesis advisor: Sarah McMenamin / Pectoral fins are evolutionarily homologous to tetrapod limbs and can serve as useful models for studying the genetic and hormonal factors regulating appendage development. To test the roles of thyroid hormone (TH) in the development of these appendages, we examined the morphogenesis of zebrafish pectoral fins under euthyroid (EuTH) or hypothyroid (hypoTH) conditions. TH plays an important role in modulating the development of the pectoral fin endoskeleton, as well as the proximo-distal patterning of the fin rays. Additionally, in HypoTH fish, shh was expressed in the same domains, but at ~50% of WT expression levels. Nuclear TH acts by binding to dual-action receptors, including Thrab, which represses or activates expression depending on interaction with the TH ligand. When Thrab was absent in HypoTH fish, we found that many elements of the HypoTH phenotype were rescued, suggesting TH relieves Thrab- mediated repression. We also found that TH modulates the development of the musculature surrounding the pectoral fin. Lastly, we generated CRISPR-Mediated knockouts of dio1 and dio3b, to learn how the deiodination of TH may be affecting the development of the pectoral fin. / Thesis (BS) — Boston College, 2023. / Submitted to: Boston College. College of Arts and Sciences. / Discipline: Departmental Honors. / Discipline: Biology.
43

The Effects of Lead Toxicity on Thyroid Hormone Physiology in the Developing Brains of Xenopus laevis Tadpoles

Dahora, Lara Iza 17 July 2023 (has links)
This dissertation focuses on the effects of lead (Pb) on the expression of thyroid hormone distributor proteins and how that affects the developing brain in Xenopus laevis tadpoles. Previous work has shown that Pb has the ability to dysregulate thyroid hormone (TH)-signaling in vertebrates and that Pb can impair brain development. This dissertation reports results for a series of Pb-treatment experiments conducted in Xenopus laevis tadpoles. The first primary hypothesis of this dissertation is that Pb impairs TH-dependent mechanisms of brain development. The second primary hypothesis of this dissertation is that Pb-induced impairments of brain development happen via dysregulation of thyroid hormone distributor proteins (THDPs) transthyretin (TTR) and β-trace. Analyses of the effects of Pb on overall body growth showed dose-dependent decreases in body length with increasing concentrations. Evaluation of the effect of Pb on tectal size and cell death in the developing brain yielded bimodal changes that depended upon Pb concentration in both features. Furthermore, Pb impaired TH-induced changes in brain development, including neurogenesis and brain volume. Pb abolished the T4-mediated increase in proliferating cell nuclear antigen (PCNA) expression, while having only marginal effects on neuronal regeneration related protein (NREP) and Krueppel-like factor 9 (klf9). Analyses of the effects of Pb on TTR and β-trace expression yielded results demonstrating a significant decrease in expression of both proteins in response to Pb-treatment. Contrary to prior studies in the literature, I demonstrate here that TTR is present in the brains of Xenopus. While electroporation of TTR morpholino did result in fewer TTR puncta, electroporation with morpholinos for TTR and β-trace knock down did not mimic the effects of Pb on neurogenesis. However, overexpression of these proteins in the choroid plexus (CP) of these animals was sufficient to produce an increase in neurogenesis. Finally, overexpression of these proteins was sufficient to ameliorate the effects of Pb-treatment on neurogenesis. The results affirm both the primary and secondary hypotheses, illustrating that Pb does, indeed, impair TH-mediated mechanisms of brain development and that these impairments are mitigated by dysregulation of TTR and β-trace. / Doctor of Philosophy / This dissertation focuses on the effects of lead (Pb) poisoning on thyroid hormone (TH)-mediated mechanisms of brain development in Xenopus laevis tadpoles. The work detailed here seeks to shine a light on the effects of Pb on brain development and one mechanism by which those effects may be mediated. This dissertation details experiments done in Xenopus laevis tadpoles, which are a prime animal model for studying environmental toxicants, especially those that disrupt TH physiology. This dissertation focuses on two primary hypotheses within a two journal manuscript format. The first primary hypothesis of this dissertation is that Pb impairs TH-dependent mechanisms of brain development. The second primary hypothesis of this dissertation is that Pb-induced impairments of brain development happen via dysregulation of thyroid hormone distributor proteins (THDPs) TTR and β-trace. The results found in this dissertation are consistent with the conclusions that Pb impairs TH-mediated mechanisms of brain development and that those impairments are mitigated by dysregulation of THDPs in the brain and body.
44

Deiodination of Thyroid Hormones by Iodothyronine Deiodinase Mimics

Manna, Debasish January 2013 (has links) (PDF)
Thyroxine is the main secretory hormone of thyroid gland and it is produced in thyroglobulin by thyroid peroxidase/hydrogen peroxide/iodide system. After biosynthesis and secretion of thyroxine, it undergoes multiple metabolic reactions. The most important metabolic pathway is the stepwise deiodination from the inner ring or outer ring. Removal of one of the outer ring or phenolic ring iodines of biologically less active T4, leads to the formation of 3,5,3'-triiodothyronine or T3, a compound which is biologically more active. On the other hand, removal of one of the inner ring or tyrosyl ring iodines gives 3,3',5'-triiodothyronine (3,3',5'-T3 or rT3) which is a biologically inactive thyroid hormone. Three enzymes involved in this activation and inactivation pathway of thyroid hormones are known as iodothyronine deiodinases (IDs), which are dimeric integral-membrane selenoproteins. Depending upon the sequence and substrate specificity, three iodothyronine deiodinase enzymes have been identified, iodothyronine deiodinase-1 (ID-1), iodothyronine deiodinase-2 (ID-2) and iodothyronine deiodinase-3 (ID-3). ID-1 can catalyze both inner ring and outer ring deiodination of thyroid hormones whereas, ID-2 is selective to the outer ring deiodination. The type-1 and -2 deiodinases (ID-1 and ID-2) produces the biologically active hormone 3,5,3′-triiodothyronine (T3). These two enzymes also convert 3,3′,5′-triiodothyronine (reverse T3 or rT3) to 3,3′-diiodothyronine (3,3′-T2) by outer-ring deiodination (Scheme 1). The type-3 deiodinase (ID-3) catalyzes the convertion of T4 to rT3 by an inner-ring deiodination pathway. Apart from deiodination, there are several alternate pathways of thyroid hormone metabolism, which include sulfate conjugation and glucoronidation of the phenolic hydroxyl group of iodothyronines, the oxidative deamination and decarboxylation of the alanine side chain to form thyroacetic acid and thyronamines, respectively. Glucoronidation and sulfate conjugation changes the physico-chemical properties of iodothyronines dramatically. This thesis consists of five chapters. The first chapter provides a general introduction of biosynthesis of thyroid hormones and followed by deiodination by three iodothyronine deiodinase enzyme. This chapter also provides an overview of thyroid hormone transport and different transport proteins and their mode of binding with thyroid hormones. Apart from this, this chapter also provides a brief overview on other thyroid hormone metabolites. In the second chapter of the thesis, initial attempts in the development of different iodothyronine deiodinase mimics have been discussed. Goto et al have shown that the sterically hindered selenol 1 converts the thyroxine derivative 3 (N¬butyrylthyroxine methyl ester) to the corresponding triiodo derivative 4 by an outer-ring deiodination (Scheme 2). Although the reaction was carried out in organic solvent and a relatively higher temperature (50 °C) and longer reaction time (7 days) were required for about 65% deiodination, this study also provides an experimental evidence for the formation of selenenyl iodide (2) in the deiodination of a thyroxine derivative by an organoselenol. However, only one iodine was removed from the outer ring of 3, no inner ring deiodination was detected (Scheme 2). Interestingly, when compound 5 was treated with selenol 1 under similar conditions, no deiodination was observed (Scheme 3). This leads to assumption that presence of free phenolic hydroxyl group is important for the deiodinase activity. Based on this experimental observation, they proposed a mechanism which involves an enol¬keto tautomerism of the phenolic hydroxyl group. In the case of thyroxine, the outer-ring can undergo enol-keto tautomerism, whereas due to lack of free hydroxyl group, the inner ring cannot undergo similar kind of tautomerism. The enol-keto tautomerism probably makes the outer ring iodines more reactive than the inner ring iodines of thyroxine. We have developed tthe first chemmical modell for the inneer ring deioddination of TT4 and T3 by type 33 deiodinase . We have shown that naphthyl-baseed selenol 6 bearing a thhiol group in the cloose proximitty to the sellenium act aas an excelleent model foor ID-3 by selectively deiodinatting T4 andd T3 to prodduce rT3 annd 3,3'-T2, rrespectively,, under physiological relevant conditions. When 2 equuivalent of ccompound 66 was emplooyed in the assay, an almost quuantitative cconversion oof T4 to rT3 was observeed within 300 hours and there was no indicaation of the fformation off T3 or 3,3'-TT2. When the selenol group was repplaced with a thiol group in compouund 7, the ddeiodinase activity wwas decreassed. On thee other handd, when thee thiol groupp was replaaced with selenol mmoiety in commpound 8, thhe deiodinasse activity drramatically iincreased wiithout any change iin the selecttivity. Comppounds 10 and 11 havving N-methhylamino grooup were found too be more aactive than the correspponding unssubstituted ccompounds 7 and 8, respectively. However, introduction of a secondary amine adjacent to the selenol moiety into the compound 9 significantly reduces the deiodinase activity. In the third chapter synthesis, deiodinase activity and mechanism of deiodination of a series of peri-substituted naphthalene derivatives is discussed. Iodobenzene was used as halogen bond donor for the DFT calculations. From the orbital analysis it is observed that there is perfect orbital symmetry match between the HOMO of compound 8 (selenolate form) and LUMO of iodobenzene. When the selenolate form of 1-selenonaphthol interacts with iodobenzene, a halogen bonded adduct is formed. The negative charge on the selenium center decreases as it donates electron pair to the σ* orbital of C–I bond in iodobenzene and as a consequence the positive charge on the iodine center decreases (Figure 1). Addition of iodobenzene to 1-selenonaphthol led to a significant downfield shift in 77Se NMR spectrum of 1-selenonaphthol and with an increase in the concentration of iodobenzene, more downfield shift in the signal was observed. Figure 1. The charges obtained from Natural Bond Orbital (NBO) analysis for the selenolate form of (a) 1-selenonaphthol (b) iodobenzene, (c) halogen-bonded adduct On the basis of experimental end theoretical data, a mechanism for the deiodination of T4 by compound 8 is proposed. According to the mechanism, the initial interaction of one of the selenol moieties with an iodine leads to the formation of halogen bond. The transfer of electron density from selenium to the σ* orbital of the C−I bond generates a σ-hole or partial positive charge on the selenium atom, which facilitates an interaction between the halogen bonded selenium atom and the free selenol (selenolate) moiety (intermediate 12). The selenium−selenium interaction (chalcogen bond) strengthens the halogen bond, leading to a heterolytic cleavage of the C−I bond. The protonation of the resulting carbanion leads to the formation of rT3. On the other hand, the formation of an Se−Se bond produces the diselenide 13 with elimination of iodide as HI. The reductive cleavage of the Se−Se bond in compound 13 regenerates the diselenol 8 (Figure 2). In the fourth chapter deiodination of sulfated thyroid hormones is discussed. Sulfate conjugation is an important step in in the irreversible inactivation of thyroid hormones. Sulfate conjugation of the phenolic hydroxyl group stimulates the inner ring deiodination of T4 and T3 but it blocks the outer ring deiodination of T4 by ID-1. The thyroxine sulfate (T4S) undergoes faster deiodination as compared to the parent thyroid hormone T4. Only ID-1 catalyzes the deiodination of sulfated thyroid hormones. In contrast, ID-2 and ID-3 do not accept T4S and/or T3S as substrate. We have shown that iodothyronine sulfates can be readily deiodinated by synthetic deiodinase model compound 8 and its derivatives. In contrast to the inner ring-selective deiodination of T4, the synthetic compounds loses the selectivity and mediate both inner and outer-ring deiodination of T4S and outer ring deiodination of rT3S. From this study, we have also proposed that the enol-keto tautomerism is probably not required for the outer ring deiodination and the strength of halogen bonding controls the regioselective deiodination by model compounds. In the fifth chapter, the mechanism of inhibition of iodothyronine deiodinases by PTU and IAA is discussed with the help of model compounds. In the model study, it has been observed that compound 8 does not form a stable Se-I intermediate (14), which is essential for the formation of Se-S covalent bond with PTU. As a consequence, the deiodination of T4 by compound 8 is not inhibited by PTU. This study supports the proposal that ID-3 does not follow a ping-pong bi-substrate pathway for deiodination and may not form a stable E-Se-I intermediate, which is responsible for the insensitivity of ID-3 towards PTU. The biphenyl based diselenol 15 reacts with IAA and iodoacetamide to form the corresponding carboxymethylated product 17. On the other hand, compound 8 does not undergo the expected carboxymethylation by IAA and iodoacetamide, but they readily deiodinate both IAA and iodoacetamide. Based on this model study, a possible model is proposed for the insensitivity of ID-3 towards IAA. Iopanoic acid (18) is a well known radiocontrast agent and is used as adjunctive therapy with PTU and CBZ for the treatment of thyrotoxicosis.[9] We show in this chapter that iopanoic acid undergoes monodeiodination by compound 8 under physiological relevant conditions. The deiodinated products (19 and 20) from iopanoic acid are characterized by NMR spectroscopy and single crystal X-ray crystallography. It is observed that after monodeiodination, the strength of halogen bonding decreases and therefore, the monodeiodinated products do not undergo further deiodination.
45

Efeito da triiodotironina e do GC-1, um tireomimético seletivo pela isoforma b do receptor de hormônio tireoideano, sobre parâmetros histomorfométricos e biomecânicos do tecido ósseo de roedores adultos. / Effect of triiodothyronine and GC-1, a thyroid hormone receptor b-selective thyromimetic, on histomorphometric and biomechanical parameters of bone tissue of adult rodents.

Costa, Cristiane Cabral 03 November 2008 (has links)
Ratas adultas foram tratadas com 2.5, 5, 10, 20 e 40x a dose fisiológica de triiodotironina (T3) por 10 semanas. Houve redução, dose-dependente, da massa óssea, volume e espessura trabecular (Tb.Th), e espessura de osso cortical. Até a dose de 10xT3, houve aumento na taxa de formação óssea (BFR). Doses maiores de T3 reduziram a BFR, e a reabsorção óssea. Esses dados mostram que, até um certo grau de tireotoxicose, a osteopenia é resultado de aumento da formação e reabsorção ósseas, com predomínio da última. Em graus mais elevados, a osteopenia é causada por redução no remodelamento ósseo, com predomínio da atividade reabsortiva. Em seguida, comparamos os efeitos do T3 e GC-1, um tireomimético seletivo pelo receptor b de T3 (TRb), no osso de camundongos fêmeas adultas. Na tíbia, o T3 reduziu a resistência, rigidez e resiliência, enquanto o GC-1 aumentou esses parâmetros e a Tb.Th, o que mostra que o GC-1 melhora a qualidade óssea. Considerando-se a seletividade do GC-1 pelo TRb, esses achados sugerem que o TRb medeia predominantemente ações positivas do T3 no osso. / Adult rats were treated with 2.5, 5, 10, 20 and 40x the physiological dose of triiodothyronine (T3) for 10 weeks. There was a dose-dependent reduction in bone mass, trabecular volume and thickness (Tb.Th), and cortical thickness. Up to 10xT3, there was an increase in the bone formation rate (BFR). Higher doses of T3 decreased BFR and bone resorption. These data show that, up to a certain degree of thyrotoxicosis, osteopenia is the result of an increase in bone formation and resorption, with a prevalence of resorption. In more severe thyrotoxicosis, the osteopenia is caused by a reduction in bone remodeling, with a predominance of bone resorption. Then, we compared the effects of T3 and GC-1, a thyromimetic that is selective for T3 receptor b (TRb), on bone of adult female mice. T3 treatment decreased tibial resistance, stiffness and resilience, while GC-1 increase these parameters and Tb.Th, showing that GC-1 improves bone quality. Considering the selectiveness of GC-1 for TRb, these findings suggest that TRb mediates mainly positive actions of T3 in the bone.
46

Efeito da triiodotironina e do GC-1, um tireomimético seletivo pela isoforma b do receptor de hormônio tireoideano, sobre parâmetros histomorfométricos e biomecânicos do tecido ósseo de roedores adultos. / Effect of triiodothyronine and GC-1, a thyroid hormone receptor b-selective thyromimetic, on histomorphometric and biomechanical parameters of bone tissue of adult rodents.

Cristiane Cabral Costa 03 November 2008 (has links)
Ratas adultas foram tratadas com 2.5, 5, 10, 20 e 40x a dose fisiológica de triiodotironina (T3) por 10 semanas. Houve redução, dose-dependente, da massa óssea, volume e espessura trabecular (Tb.Th), e espessura de osso cortical. Até a dose de 10xT3, houve aumento na taxa de formação óssea (BFR). Doses maiores de T3 reduziram a BFR, e a reabsorção óssea. Esses dados mostram que, até um certo grau de tireotoxicose, a osteopenia é resultado de aumento da formação e reabsorção ósseas, com predomínio da última. Em graus mais elevados, a osteopenia é causada por redução no remodelamento ósseo, com predomínio da atividade reabsortiva. Em seguida, comparamos os efeitos do T3 e GC-1, um tireomimético seletivo pelo receptor b de T3 (TRb), no osso de camundongos fêmeas adultas. Na tíbia, o T3 reduziu a resistência, rigidez e resiliência, enquanto o GC-1 aumentou esses parâmetros e a Tb.Th, o que mostra que o GC-1 melhora a qualidade óssea. Considerando-se a seletividade do GC-1 pelo TRb, esses achados sugerem que o TRb medeia predominantemente ações positivas do T3 no osso. / Adult rats were treated with 2.5, 5, 10, 20 and 40x the physiological dose of triiodothyronine (T3) for 10 weeks. There was a dose-dependent reduction in bone mass, trabecular volume and thickness (Tb.Th), and cortical thickness. Up to 10xT3, there was an increase in the bone formation rate (BFR). Higher doses of T3 decreased BFR and bone resorption. These data show that, up to a certain degree of thyrotoxicosis, osteopenia is the result of an increase in bone formation and resorption, with a prevalence of resorption. In more severe thyrotoxicosis, the osteopenia is caused by a reduction in bone remodeling, with a predominance of bone resorption. Then, we compared the effects of T3 and GC-1, a thyromimetic that is selective for T3 receptor b (TRb), on bone of adult female mice. T3 treatment decreased tibial resistance, stiffness and resilience, while GC-1 increase these parameters and Tb.Th, showing that GC-1 improves bone quality. Considering the selectiveness of GC-1 for TRb, these findings suggest that TRb mediates mainly positive actions of T3 in the bone.
47

The chilling tail of temperature’s influence on thyroid hormone signalling in the post-embryonic developmental response of Rana catesbeiana cultured tail fin

Koide, Emily 14 September 2021 (has links)
Thyroid hormone (TH) is a critical signalling molecule for all vertebrate organisms, playing an especially crucial role in postembryonic development. Given its importance, many studies have focused on further elucidating the initial TH signal response and its method of transduction. Although the primary mechanism of TH response is genomic signalling, alternative mechanisms of early TH signal transduction have been relatively poorly studied. The North American bullfrog, Rana catesbeiana, is a useful model to study these early responses as tadpole post-embryonic development, or metamorphosis, can be experimentally induced through exposure to TH. The experimental induction of the TH signalling program leads to similar morphological endpoints as seen in natural metamorphosis in the transition of a tadpole to a juvenile froglet, such as regression of the tail. This TH-induced developmental program can also be manipulated through temperature where, as temperatures lower, developmental rate is delayed and at 5°C metamorphosis is completely stalled. Interestingly, when tadpoles exposed to TH at 5°C are introduced to permissive temperatures (24°C), an accelerated developmental program ensues, even when no more endogenous TH signal remains. Previous research has shown that this phenomenon can also be seen on the molecular level where only a select few transcripts have been shown to be responsive to TH at 5°C. However, the characteristic, if not augmented, TH response program is seen on the transcriptomic level when tadpoles are shifted to 24°C. This indicates that there is a molecular memory where the TH signal is induced in cold temperatures but not executed until more permissive temperatures arise. The extent and regulation of the transcriptomic program involved in this TH-induced molecular memory has yet to be understood. Herein we use the broader probing technique of RNA-seq analysis to identify potential components of the molecular memory. Eighty-one gene transcripts were TH-responsive at 5°C in cultured R. catesbeiana tail fin indicating that the molecular memory is more complex than previously thought. A number of these transcripts encoded regulators of transcription. Closer examination of select transcripts including a novel krüppel-like factor family member, klfX, at 5oC indicated that not all of the candidate molecular memory transcripts are regulated through active transcription and active translation is not required. When moved into 24°C an accelerated transcriptomic response occurred even when no additional TH is added, suggesting that a priming event occurs by TH exposure at 5°C allowing an accelerated metamorphosis at permissive temperatures. The molecular memory may be used as a means to isolate the initiating TH signalling response and the regulation of this program to allow further elucidation of early TH signalling in post-embryonic development. / Graduate
48

Thyroid Hormone Metabolism in the Non-Euthyroid Porcine Fetus

Erin Kay Ison (13140777) 22 July 2022 (has links)
<p>Thyroid hormone is essential for regulating adult metabolism and proper fetal development. Under normal conditions, maternal and fetal thyroid hormones are subject to metabolism at the placenta and within fetal tissues through deiodination and sulfation to regulate fetal exposure to the bioactive hormone. Disruptions of the thyroid hormone system can result in non-thyroidal illness syndrome (NTIS), which is classified as the dysregulation of thyroid hormone homeostasis. The exact cause of the alterations in circulating thyroid hormone levels during NTIS is not well- known. In comparison, hypothyroidism results from the absence of thyroid hormone production and presents as low thyroid hormone levels.</p> <p>Porcine reproductive and respiratory syndrome virus (PRRSV) crosses the late gestation placenta and causes suppression of circulating maternal and fetal thyroid hormone. Chapter 2 investigates the potential role of thyroid hormone metabolism in this disruption. Pregnant gilts were challenged with PRRSV2 (n=22) or sham inoculated (n=5) at gestation day 85. Samples were collected on day 106, and viral load was assessed in fetal serum and thymus. From the entire fetal population, three distinct subsets of fetuses representing biological extremes were identified, including uninfected with no detectable viral load (UNIF), high viral load viable (HV-VIA), or high viral load with severe meconium staining (HV-MEC). In addition, control fetuses from sham inoculated gilts (CON) were used as a reference group. Samples of fetal liver, kidney, and the corresponding fetal placenta and maternal endometrium for n=10 fetuses per group were then used to evaluate gene expression. A total of 11 genes associated with thyroid hormone metabolism including deiodinases (DIO1,2,3), sulfotransferases (SULT1A3,1B1,1C2,1E1,2A1), sulfatase (STS), and solute carriers (SLC16A2,16A10) were quantified using absolute quantification qPCR. Evidence of fetal decompensation was observed within the high viral fetuses in the form of decreased DIO1 expression within the fetal liver and increased DIO3 expression in both components of the placenta. Circulating levels of T4 and inactive thyroid hormone metabolites, reverse-triiodothyronine (rT3) and two diiodothyronines (3,5-T2 and 3,3’-T2), were measured in fetal serum. While T4 was depressed, no change was observed in circulating rT3 levels, and neither T2 metabolite reached the lower detection limit. This may suggest that alterations in thyroid hormone metabolism generate a localized effect on hormone metabolites in the respective tissues.</p> <p>Alternatively, the low levels of available T3 and T4 limit the production of downstream metabolites to be found in serum.</p> <p>The cause-and-effect relationship between PRRSV infection, fetal thyroid disruption, and the effects on fetal thyroid hormone metabolism are unclear. Therefore, Chapter 3 developed a non-pathogenic model using methimazole (MMI) to induce hypothyroidism in the late gestation fetus and evaluate the impact on fetal development and thyroid hormone metabolism. Pregnant gilts were either treated with oral methimazole or equivalent sham from gestation day 85-106 (n=4/group), followed by classification of all fetuses as live, live but meconium stained, or dead. Fetuses exposed to MMI in-utero were notably hypothyroid with significantly suppressed serum T3 and T4 and histological evidence of goiter. Surprisingly, fetuses from MMI-treated dams were substantially larger but appeared to exhibit non-allometric growth with an increase in girth but not length. The liver, kidney, and the corresponding fetal placenta and maternal endometrium were collected from a subset of 16 fetuses per group to evaluate the relative expression of five genes associated with thyroid hormone metabolism, including three deiodinases and two solute carriers known to transport thyroid hormone. Compensatory transcription of DIO3 was observed in all tissues evaluated, suggesting increased vertical transfer of maternal thyroid hormone at the placenta and decreased breakdown of thyroid hormone within fetal organs.</p> <p>The evaluation of thyroid hormone metabolism within the fetus and within the placenta has allowed us to differentiate suppressed thyroid hormone levels of the pig fetus under pathogenic and non-pathogenic conditions. In the context of PRRSV infection, the observed decompensation of thyroid hormone metabolism would further exacerbate the hypothyroid state and is therefore consistent with NTIS. In contrast, fetuses with induced thyroid hormone suppression following maternal exposure to MMI showed compensatory thyroid hormone metabolism in the same tissues. This indicates true hypothyroidism and clearly demonstrates a fetal capacity to respond to such endocrine disruption.</p>
49

Molecular analysis of thyroid hormone receptor beta and peroxisome proliferator-activated receptor gamma action

Agostini, Maura January 2010 (has links)
The nuclear receptor superfamily comprises a group of ligand-activated transcription factors that regulate the expression of target genes. They play a central role in diverse physiological pathways, and are therefore extremely important in the aetiology of various human disorders and as pharmaceutical therapeutic targets. This thesis describes molecular analyses of the thyroid hormone receptor (TR) and the peroxisome proliferator-activated receptor gamma (PPARγ), in disorders of thyroid hormone and insulin action respectively. The syndrome of Resistance to Thyroid Hormone (RTH), characterized by reduced tissue responsiveness to circulating thyroid hormones, is associated with diverse mutations in the ligand-binding domain of the thyroid hormone β receptor, localizing to three clusters around the hormone binding cavity. The first part of this thesis describes three novel RTH mutations (S314C, S314F, S314Y), due to different amino acid substitutions in the same codon, occurring in six separate families. Characterization of these mutant receptors showed marked differences in their functional impairment. In the second part of the thesis I report detailed functional studies of natural and synthetic receptor agonists with loss-of-function PPARγ mutants (P467L; V290M), previously identified in patients with severe insulin resistance, type 2 diabetes mellitus and hypertension. Both PPARγ mutants act as dominant negative inhibitors of wild type receptor (WT) action because of their failure to fully dissociate from corepressors. My results provide evidence that tyrosine-based rather than thiazolidinedione PPARγ agonists, may represent a more rational therapeutic approach to restoring mutant receptor function and ameliorating insulin resistance in our patients. Then, in an unrelated kindred a different, digenic mechanism of insulin resistance, with a combination of loss-of-function mutations in PPARγ and PPP1R3 (muscle-specific subunit of protein-phosphatase 1 mediating glycogen synthesis) is described. Functional characterisation of these mutant proteins provides unique insights into the complex interplay between this nuclear receptor and a second metabolic signalling pathway. Finally, three novel heterozygous mutations, in the ligand and DNA binding domains of PPARγ, identified in three unrelated subjects with partial lipodystrophy, severe insulin resistance, dyslipidaemia and hypertension are described. Their functional characterization suggests that they inhibit WT action via a novel, non DNA-binding interference mechanism.
50

Hormones thyroïdiennes et désordres métaboliques / Thyroid hormones and metabolic disorders

Billon, Cyrielle 27 June 2012 (has links)
Les hormones thyroïdiennes jouent un rôle dans de nombreux processus métabolique tels que le développement, la croissance et le contrôle du métabolisme. Les HT se fixent sur leurs récepteurs nucléaires, les TR (TRalpha et beta). Ces TR sont des facteurs de transcription dont l’activité est contrôlée par la fixation de leur ligand, ils appartiennent à la super famille des récepteurs nucléaires d’hormone. Au cours de ma thèse je me suis intéressée aux rôles des TR dans deux contextes particuliers. Dans un premier temps, j’ai pu mettre en évidence le rôle de TRbeta dans la régulation du métabolisme hépatique via l’activation d’un gène clé ChREBP permettant la détection du glucose. Par l’utilisation d’animaux transgéniques et des systèmes in vitro, j’ai pu montrer que TRbeta régule positivement l’expression de ChREBP via le fixation sur son élément de réponse présent de le promoteur. Nous avons pu montrer que cette activation est isoforme spécifique, indépendante d’un autre récepteur nucléaire LXR. Dans un deuxième temps, j’ai montré que l’autre isoforme de TR, TRalpha est impliqué dans le développement de l’athérosclérose, une maladie cardiovasculaire. Par l’utilisation d’un modèle de souris transgénique, j’ai pu mettre en évidence que TRalpha possède à la fois un rôle anti-inflammatoire et également il est capable de stimuler l’élimination du cholestérol par les macrophages. L’absence de ce récepteur induit une augmentation du développement de la maladie ainsi que des cytokines circulantes chez la souris. Par l’utilisation d’un système in vitro, j’ai pu mettre en évidence que l’absence de TRalpha diminue l’efflux de cholestérol dans les macrophages de souris. Ces données suggèrent un nouveau rôle des HT/TR dans le développement de pathologies humaines, notamment un effet anti-inflammatoire longtemps supposer mais mis en évidence que très récemment. / Thyroid hormones (TH) play a role in many processes such as development, growth and metabolic control. HT bind to their nuclear receptors, the TR (TRalpha and beta). TRs belong to the superfamily of nuclear hormone receptors. These TRs are transcription factors whose activity is controlled by the binding of their ligand. During my PhD thesis I focused on the roles of TR in two contexts. Initially, I highlighted the role of TRbeta in the regulation of the hepatic metabolism via the activation of the key gene ChREBP, a glucose-responsive transcription factor. Using transgenic animal models and in vitro systems, I showed that TRbeta up regulates the expression of ChREBP via binding to its response element present in the promoter. I have shown that this activation is isoform specific and independent of another nuclear receptor LXR. In a second part, I demonstrated that the TRalpha isoform is involved in the development of atherosclerosis, a cardiovascular disease. Using a transgenic mice model, I observed that TRalpha has an anti-inflammatory effect and it is also able to stimulate the reverse cholesterol transport by macrophages. The absence of this receptor induces an increase in the development of the disease as well as in the level of circulating cytokines in mice. The deletion of TRalpha decreases the cholesterol efflux in bone marrow derived macrophages in vitro and it is correlated with a decrease of ABCA1 expression. All these data suggest a novel role of HT / TR in the development of human pathologies, including an anti-inflammatory role assumed, but recently demonstrated.

Page generated in 0.0658 seconds